Updated NCCN® Guidelines Recognize MammaPrint® UltraLow Risk Result, Highlighting its Clinical Utility for Women with Early-Stage Breast Cancer Who Can Safely Forgo Toxic Treatments with Excellent Survival Rates

 

Exelixis and Sairopa Announce US FDA Clears Investigational New Drug Application for ADU-1805 in Patients with Advanced Solid Tumors

 

Best's Market Segment Report: P&I Clubs See Improving Underwriting Results but Investment Environment Remains Challenging

 

Pershing Square Holdings, Ltd. Provides Annual Investor Update Presentation

 

Fluence Supporting Premium Dutch Floriculture Brands to Future-Proof and Increase Sustainability

 

Kite’s Tecartus® CAR T-Cell Therapy Demonstrates Overall Survival Benefit in Three-Year Follow-up of Pivotal ZUMA-3 Trial in Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia

 

Conceal Partners with SBL Cyber Monitoring to Bring Innovative Security Solutions to the Netherlands

 

Dawex, Fraunhofer ISST and TNO Agree to co-Propose a Pre-Standardization Program on Trusted Data Transaction

 

LivaNova Initiates Limited Commercial Release in Europe of the Essenz Perfusion System for Cardiopulmonary Bypass Procedures

 

The IKEA Foundation Commits €10 Million to Provide Emergency Assistance in Türkiye and Northern Syria